CEWG January 09 Full Report - National Institute on Drug Abuse

EpidEmiologic TrEnds in drug AbusE: HigHligHTs And ExEcuTivE summAry
Other Drugs (BZP, TFMPP, Foxy Methoxy, Carisoprodol)
BZP (1-Benzylpiperazine). In the first half
of 2008, BZP emerged among the top 25 identified
drugs in NFLIS forensic laboratories in 16 of
22 <strong>CEWG</strong> areas. The six exceptions were: Albuquerque,
Atlanta, Cincinnati, Philadelphia, New
York City, and San Diego. This contrasts with CY
2007 when none of the 22 <strong>CEWG</strong> areas, with the
exception of Detroit, listed BZP-containing drug
items among the top 25 drugs identified in forensic
laboratories. In Detroit, 11 BZP items were
identified in CY 2007, representing 0.1 percent
of all drug items identified, while in the first half
of 2008, 20 items, or 0.6 percent of drug items in
the half-year period, were so identified. In Seattle,
for example, 1.8 percent (n=29) of drug items
identified in the first half of 2008 contained BZP,
compared with none in CY 2007. Section II, table
1 shows BZP rankings among the top 10 most
frequently identified drug items in NFLIS data in
the first half of 2008. BZP ranked 7th in Seattle
and Chicago, 9th in Washington, DC and Miami/
Dade County, and 10th in Honolulu and Detroit.
TFMPP or 1-(3-Trifluoromethylphenyl)
Piperazine. The identification of this drug in top
25 NFLIS data for the first half of 2008 was localized
to two areas—Atlanta and Washington, DC.
Atlanta reported an increase in items containing
TFMPP in the first half of 2008, compared with
CY 2007, reporting 16 such drug items in CY
2007 and 117 in the first half of 2008. This represents
an increase from 0.1 percent to 1.7 percent
of drug items identified in the respective periods.
In the first half of 2008 forensic laboratory data,
TFMPP ranked seventh in Washington, DC and
eighth in frequency among drug items identified
in Atlanta (section II, table 1).
Foxy or Foxy Methoxy (5-Methoxy-N,N-
Diisopropyltryptamine, or 5-MeO-DIPT). No
Foxy Methoxy drug items were identified in any
<strong>CEWG</strong> areas among the top 25 in CY 2007, with
the exception of Seattle (n=5). In the first half of
2008, however, Denver (n=91) and Phoenix (n=3)
both reported identification of this drug. Increasing
from none in CY 2007, 19 drug items were
identified in Denver in the first half of 2008, 18 of
which this drug represented 0.5 percent of total
drug items in that area. Eighteen of the 19 such
drug items identified were identified in Arapahoe
County, a suburban county south of Denver in the
Denver MSA. This drug ranked 10th among the
most frequently identified drug items in Denver
in this reporting period (section II, table 1).
Carisoprodol. Drug items containing carisoprodol
ranked eighth in Texas and tenth in
Atlanta, Los Angeles, and Phoenix among the
most frequently identified items in the first half
of 2008 for 22 <strong>CEWG</strong> areas (section II, table 1).
<strong>Report</strong>ed among the top 25 most commonly identified
drugs in both CY 2007 and the first half of
2008, carisoprodol items increased slightly over
the two periods in Atlanta and Los Angeles. In
Atlanta, carisoprodol-containing drug items represented
0.7 percent (n=103) of drug items identified
in CY 2007 and 0.9 percent (n=60) in the first
half of 2008, while they represented 0.2 percent
(n=123) and 0.3 percent (n=86) in the respective
periods in Los Angeles. Percentages were stable
over the two reporting periods for Phoenix, San
Diego, and Texas.
98
Proceedings of the Community Epidemiology Work Group, <strong>January</strong> 20<strong>09</strong>